Navigation Links
VisEn Acquires Key Fluorescence Agent Intellectual Property Portfolio and Technology Platforms From Bayer Schering Pharma
Date:1/28/2010

BEDFORD, Mass., Jan. 28 /PRNewswire/ -- VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today that it has acquired the fluorescence imaging agent intellectual property portfolios and related technology platforms from Bayer Schering Pharma AG, Germany.  The patent acquisition includes over 45 issued patents worldwide covering a wide range of fluorescence agent constructs and imaging methods, and consolidates VisEn's patent and technology leadership position in the emerging markets of fluorescence imaging from preclinical research through clinical molecular diagnostics.

"We have closely tracked the very high quality of Bayer Schering Pharma's fluorescence agent technologies and extensive patent portfolios over the last decade, and we are pleased to now integrate these platforms into VisEn's programs," said Kirtland Poss, President and CEO of VisEn Medical.  "The acquisition of these assets significantly expands VisEn's patent coverage of in vivo fluorescent imaging agents, and adds to our R&D capability and pipeline of preclinical agent products and clinical imaging agents going forward."

With this acquisition, VisEn's intellectual property portfolio covering fluorescence imaging agents now includes over 150 patents and patent applications worldwide.  The collective patent estate provides comprehensive coverage of a broad range of core agent components and chemistries, as well as key preclinical and clinical applications and methods.  Included in the acquired portfolio are key patents covering physiologic agents, bioconjugates and targeted fluorescence agents, and certain activatable imaging agents for measurement of diverse biomarker activity in living systems.  With the addition of these new platforms, Vi
'/>"/>

SOURCE VisEn Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
2. VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE
3. VisEn Launches New Cat B 680 FAST(TM) Fluorescence Molecular Imaging Agent
4. VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting
5. VisEn Launches New OsteoSense(R) 800 and VivoTag(R) 800 Fluorescence Molecular Imaging Agents
6. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
7. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
8. U.S. Preventive Medicine Acquires Specialty Disease Management
9. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
10. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
11. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Research and Markets has announced the addition of ... 9th Edition" report to their offering. ... market and all of its segments, providing customers with a ... Business Planning. This is the ninth edition of ... and early 2014. New entrants, new technologies have entered the ...
(Date:9/15/2014)... , Sept. 15, 2014  Decision Resources Group finds ... to expand, increasing pressure to control expenditures will result ... emphasize that although type 2 diabetes drugs will generally ... likely to enforce additional restrictions on expensive agents. Surveyed ... , Germany , Italy ...
(Date:9/15/2014)... 15, 2014 Following ... to exit or end market development and ... Tropane Alkaloid APIs (active pharmaceutical ingredients) - ... Homatropine Hydrobromide, Digoxin and Cimetropium Bromide - ... commitment to maintain production and regulatory (Drug ...
Breaking Medicine Technology:The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 2The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 3Interviewed Payers in the EU5 Anticipate Increasing Prescribing Constraints for Premium-Priced Type 2 Diabetes Agents 2Interviewed Payers in the EU5 Anticipate Increasing Prescribing Constraints for Premium-Priced Type 2 Diabetes Agents 3Alchem International Commits to Tropane Alkaloid APIs and Extends Production and Regulatory Support to Resolve Supply Gap 2
... Reportlinker.com announces that a new market ... Infectious Immunology Reagents, ... Analysis, Competitive Landscape and Market Forecasts to ... Infectious Immunology Reagents, Instruments ...
... Reportlinker.com announces that a new market research report is ... - Global Drug Forecasts and Treatment Analysis to 2020 ... Bladder Cancer - Global Drug Forecasts ... Summary GlobalData, the ...
Cached Medicine Technology:Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 2Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 3Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 4Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 5Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 6Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 7Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 8Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 9Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 10Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 11Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 12Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 13Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 14Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 15Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 16Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 17Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 18Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 19Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 20Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 21Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 22Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 23
(Date:9/15/2014)... Crosley Law Firm is proud to announce that ... named to the list of Super Lawyers in 2014, continuing ... injury law. , Before receiving the designation of “Super ... First, they must come highly recommended by a lawyer from ... during the past year by obtaining certain honors, results, or ...
(Date:9/15/2014)... Imaging can be a cost-effective way to identify people ... intervention, according to a new modeling study published online ... study looked at people with asymptomatic carotid artery stenosis, ... to the head due to atherosclerosis, or plaque buildup. ... to 20 percent of ischemic strokes, which result from ...
(Date:9/15/2014)... September 15, 2014 Today, Zane Benefits, ... Zions Bank’s Speaking on Business radio show. , ... product, so employers know it doesn’t make sense to ... can also save the employer and employee as much ... host of Zions Bank's Speaking on Business , ...
(Date:9/15/2014)... used brain scans to predict how young children learn ... children with dyslexia and other reading difficulties before they ... children usually learn to read for the first time ... according to the authors. In the study, researchers examined ... to read formally at school and tracked their white ...
(Date:9/15/2014)... analysis from the prospective Prostate, Lung, Colorectal and Ovarian ... moderate baldness affecting both the front and the crown ... 40% increased risk of developing aggressive prostate cancer (usually ... relative to non-aggressive prostate cancer) later in life, compared ... link between other patterns of baldness and prostate cancer ...
Breaking Medicine News(10 mins):Health News:Thomas A. Crosley and R. Andrew Rodriguez Named 2014 Super Lawyers 2Health News:Imaging identifies asymptomatic people at risk for stroke 2Health News:Imaging identifies asymptomatic people at risk for stroke 3Health News:Zane Benefits Featured on Zions Bank Speaking on Business 2Health News:Study first to use brain scans to forecast early reading difficulties 2Health News:Certain form of baldness at age 45 linked to higher risk of aggressive prostate cancer 2
... of normal aging process , , WEDNESDAY, Aug. 27 (HealthDay News) ... free of dementia will nonetheless undergo an accelerated drop in ... death, a new study reveals. , Verbal ability, spatial reasoning ... decline, which is not, the researchers stressed, a routine part ...
... LLC, WARP,Robotics, LLP, and Planet Earth Engineering, LLP Corporate ... Carolina Corporation today,announced that the company has reached an ... the month of September., Patrick & Sharalyn LaRive ... subsidiary of WARP Services, LLC are delighted at the ...
... and personalized care to dialysis patients ... ... a leading,provider of kidney care services, announced today that its specialty ... be filled today during a special celebration at DaVita Rx,headquarters in ...
... Hospital will be Model for Pediatric ... ... today revealed new details about their visionary plans to,shape the ,Children,s ... health throughout Central Florida and be a,model for pediatric hospitals beyond ...
... August 27, 2008 Researchers from St. Louis University ... is 99.1 percent accurate in diagnosing pancreatic neoplasms (abnormal growths ... (EUS) because of CT and/or MRI reports of two common, ... (HOP) or dilation of the pancreatic duct (PD). The study ...
... BALA CYNWYD, Pa., Aug. 26 Philadelphia,Insurance Companies ... Volunteer Accident,Insurance through its partnership with Life Insurance ... provided for a variety of niches,including non-profits, social ... and substance abuse rehabilitation facilities.,The plan provides up ...
Cached Medicine News:Health News:Mental Skills Can Decline Years Before Dying 2Health News:Mental Skills Can Decline Years Before Dying 3Health News:Habitat for Humanity and WARP Robotics Team Up 2Health News:Habitat for Humanity and WARP Robotics Team Up 3Health News:Specialty Renal Pharmacy Delivers One Millionth Prescription 2Health News:Florida Hospital Unveils New Details, Name for 'Children's Hospital of the Future' 2Health News:Florida Hospital Unveils New Details, Name for 'Children's Hospital of the Future' 3Health News:Florida Hospital Unveils New Details, Name for 'Children's Hospital of the Future' 4Health News:Florida Hospital Unveils New Details, Name for 'Children's Hospital of the Future' 5Health News:Endoscopic ultrasound highly accurate in evaluating ambiguous radiographic findings of the pancreas 2Health News:Endoscopic ultrasound highly accurate in evaluating ambiguous radiographic findings of the pancreas 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: